During the past decade, Praxis Dilltal conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Praxis Dilltal" are "Hypercholesterolemia" (1 trials), "Mixed Dyslipidemia" (1 trials), "Psoriatic Arthritis" (1 trials), "Rheumatoid Arthritis" (1 trials) and "Sacroilitis" (1 trials). Many other conditions were trialed in "Praxis Dilltal" in a lesser frequency.

Most popular intervention types in "Praxis Dilltal" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Bempedoic acid and/or its fixed-dose combination with ezetimibe" (1 trials), "Filgotinib" (1 trials), "Placebo oral tablet" (1 trials) and "Tofacitinib 5 MG Oral Tablet [Xeljanz]" (1 trials). Other intervention names were less common.

The vast majority of trials in "Praxis Dilltal" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Praxis Dilltal". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Praxis Dilltal, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Praxis Dilltal, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".